HOCl-producing electrochemical bandage is active in murine polymicrobial wound infection

New approaches are needed to combat the rise of antimicrobial-resistant infections. The HOCl-producing electrochemical bandage (e-bandage) leverages <i>in situ</i> generation of HOCl, a natural biocide, for broad-spectrum killing of wound pathogens. Unlike traditional therapies that may exhibit limited activity against biofilms and antimicrobial-resistant organisms, the e-bandage offers a potent, standalone solution that does not contribute to further resistance or require adjunctive antibiotic therapy. Here, we show the ability of the e-bandage to address polymicrobial infection by antimicrobial resistant clinical isolates of <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>, two commonly isolated, co-infecting wound pathogens. Effectiveness of the HOCl-producing e-bandage in reducing pathogen load while minimizing tissue toxicity and avoiding the need for systemic antibiotics underscores its potential as a tool in managing complex wound infections.

Authors

Institutions

Publication Details

Journal
Microbiology Spectrum
Published
2024-08-20
DOI
https://doi.org/10.1128/spectrum.00626-24
Citations
3
Primary Topic
Wound Healing and Treatments
Type
article
Field-Weighted Citation Impact
0.75

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HOCl-producing electrochemical bandage is active in murine polymicrobial wound infection

Melissa J. Karau, Ibrahim Bozyel, Suzanne Gelston, Kerryl E. Greenwood‐Quaintance et al.
3 citations
Microbiology Spectrum
Wound Healing and Treatments
0.75
article

HOCl-producing electrochemical bandage is active in murine polymicrobial wound infection

Melissa J. Karau, Ibrahim Bozyel, Suzanne Gelston, Kerryl E. Greenwood‐Quaintance, Haluk Beyenal, Dilara Ozdemir, Derek Fleming, Robin Patel, Md Monzurul Islam Anoy, Audrey N. Schuetz, Luz Cuello, Christina A. Koscianski, Jayawant N. Mandrekar
article en
3 citations

Abstract

New approaches are needed to combat the rise of antimicrobial-resistant infections. The HOCl-producing electrochemical bandage (e-bandage) leverages <i>in situ</i> generation of HOCl, a natural biocide, for broad-spectrum killing of wound pathogens. Unlike traditional therapies that may exhibit limited activity against biofilms and antimicrobial-resistant organisms, the e-bandage offers a potent, standalone solution that does not contribute to further resistance or require adjunctive antibiotic therapy. Here, we show the ability of the e-bandage to address polymicrobial infection by antimicrobial resistant clinical isolates of <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>, two commonly isolated, co-infecting wound pathogens. Effectiveness of the HOCl-producing e-bandage in reducing pathogen load while minimizing tissue toxicity and avoiding the need for systemic antibiotics underscores its potential as a tool in managing complex wound infections.

Microbiology SpectrumVol. 12(10)
Mayo Clinic (US), Mayo Clinic in Florida (US), Washington State University (US)
National Institutes of Health, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 25%
Wound Healing and Treatments
0.75
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.